Elysium Rich Fund

Elysium Rich Corp. is a diversified, closed-end management investment company. Elysium Strategic Growth strategy leverages it's deep investment expertise, sector relationships, track record of scaling companies, and extensive portfolio to identify and invest in businesses with innovative products or services and high-quality management teams. The strategy draws on the full set of capabilities of its investment team to help these businesses thrive and grow. We target opportunities in the Americas across various health care sub-sectors, including biopharmaceuticals, medical devices, diagnostics ⁄ life science tools, providers, and other services. Elysium Rich Fund investments are opportunities in which the Fund believes that we can help commercialize or further scale the underlying product(s) or service(s). We seek situations characterized by large potential markets and unmet needs and invest with a flexible approach, including minority and majority stakes, through which we can provide sufficient capital to allow companies to grow over time.

Management Partners

Levine Leichtman Capital Partners

Levine Leichtman Capital Partners (LLCP) is an institutional asset manager that is focused on acquiring concurrent debt and equity positions in middle-market companies located primarily in the United States. Based in Beverly Hills, California, LLCP is responsible for sourcing opportunities and the day-to-day management of Atom Growth Fund's assets. LLCP has:     Over 35 years of experience    More than 150 global institutional investors    Invested in 90 companies    Managed approximately $11.2 billion of capital since inception